Genpact (G) awards 63,357 restricted share units to SVP & CLO

Rhea-AI Filing Summary

Genpact Limited reported that its SVP and Chief Legal Officer, Sydney Schaub, received an award of 63,357 common shares in the form of unvested restricted share units on 01/06/2026 at a grant price of $0 per share. Each RSU represents the right to receive one Genpact common share upon vesting. One-third of the shares underlying this RSU award will vest on each of December 8, 2026, December 8, 2027 and December 8, 2028, as long as Schaub continues in service through each vesting date. Following this grant, Schaub beneficially owned 63,357 common shares directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schaub Sydney

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/06/2026		A		63,357(1)	A	$0	63,357	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of December 8, 2026, December 8, 2027 and December 8, 2028, subject to the reporting person's continued service through each vesting date.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Sydney Schaub	01/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Genpact (G) disclose about insider equity awards in this Form 4?

The company disclosed that SVP and Chief Legal Officer Sydney Schaub received an award of 63,357 unvested RSUs on 01/06/2026 under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

What are the key terms of Sydney Schaub’s 63,357 RSU award at Genpact (G)?

Each RSU entitles Schaub to receive one Genpact Limited common share upon vesting, with the grant reported at a price of $0 per share and classified as directly owned.

How will Sydney Schaub’s Genpact (G) RSUs vest over time?

One-third of the RSUs will vest on December 8, 2026, one-third on December 8, 2027, and the final third on December 8, 2028, subject to continued service through each vesting date.

How many Genpact (G) common shares does Sydney Schaub beneficially own after this transaction?

After the reported RSU grant, Schaub beneficially owned 63,357 common shares of Genpact Limited, held in direct ownership form.

Was this Genpact (G) Form 4 transaction a purchase or a grant?

The filing shows a transaction code “A”, indicating an acquisition of 63,357 common shares through an equity award of RSUs, not an open-market purchase.

Under which plan were the Genpact (G) RSUs granted to Sydney Schaub?

The unvested RSU award was granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan, as described in the Form 4 footnote.